G-CSF and PRP in Patients With Recurrent Implantation Failure

• Status: Recruiting
• Trial end date: 2021-03-31
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of this randomized controlled trial is to determine whether granulocyte colony-stimulating factor and platelet-rich plasma can be used to enhance the IVF-ET outcomes in patients with recurrent implantation failure

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Riyadh Fertility and Reproductive Health center
• Treatments: Lenograstim; Sargramostim

Criteria

Inclusion Criteria:

• Patients with history of three or more unsuccessful IVF-ET cycles with at least 2 good quality embryos transferred

Exclusion Criteria:

• Endometriosis

• Uterine anomalies

• Asherman syndrome